Concepedia

Craig J. Reist

CJ

Statistics

Publications

23

Citations

2.7K

H-Index

18

Active since

1991

Affiliations

Duke Medical Center(Current)

Duke University Hospital

Clinical Research Institute

University of Virginia

Cleveland Clinic

Craig J. Reist is an author at Duke Medical Center specializing in medicine, monoclonal antibodies, and oncology.

Publications per year

1991–2011

23

Publications

23

Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

Cathal O’Connor, Randall C. Starling, Adrian F. Hernandez et al. · New England Journal of Medicine · 2011 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas.

Carol J. Wikstrand, Laura P. Hale, Surinder K. Batra et al. · PubMed · 1995 · 471 citations

Pharmacy, Cancer Biology, Oncology +17

Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)

Adrian F. Hernandez, Christopher M. O’Connor, Randall C. Starling et al. · American Heart Journal · 2008 · 148 citations

Medicine, Cardiology, Pharmacology +13

Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenografts.

Craig J. Reist, Gary E. Archer, Shekar N. Kurpad et al. · PubMed · 1995 · 106 citations

Medicine, Molecular Biology, Oncology +15

Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody.

Catherine Foulon, Craig J. Reist, Darell D. Bigner et al. · PubMed · 2000 · 79 citations

Medicine, Oncology, Pharmacology +17

1–5 of 23